Lataa...
Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer’s Disease Clinical Trial Recruitment
INTRODUCTION: The apolipoprotein E (APOE) gene is the strongest known genetic risk factor for sporadic Alzheimer’s disease (AD). APOE can be used as an enrichment strategy or inclusion criterion for AD prevention trials. Personal genomics companies market direct-to-consumer (DTC) genetic tests, incl...
Tallennettuna:
| Julkaisussa: | Alzheimer Dis Assoc Disord |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8044253/ https://ncbi.nlm.nih.gov/pubmed/33060367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WAD.0000000000000421 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|